Waldenström macroglobulinemia cells as models for the regulation of human IgM 2252298

K Kailey Paar M Mona Karbalivand (University of New Hampshire) J Joseph Sevigny (University of New Hampshire) W W Kelley Thomas (University of New Hampshire) S Sherine Elsawa (1University of New Hampshire, Molecular, Cellular and Biomedical Sciences, Durham, United States)

Abstract

Abstract Introduction Waldenström macroglobulinemia (WM) is a B cell lymphoma distinguished by the overproduction of a monoclonal IgM antibody and the lack of class switch recombination (CSR). Despite the presence of apparently normal CSR machinery, it remains unknown why WM B cells fail to undergo CSR or what mechanisms regulate the overproduction of IgM. To date, three WM cell lines (BCWM.1, MWCL-1, and RPCI-WM1) have been generated from different patients. Each cell line secretes a monoclonal IgM, though at varying levels. The regulation of human IgM transcription relies on studies of polyclonal B cells from tonsils or peripheral blood, making it challenging to study regulation at the transcriptional level. Methods Through bulk RNA sequencing of B cell receptors (BCRs), we have identified V, (D), and J gene segment usage in the heavy (H) and light (L) chains of each cell line. We performed PacBio HiFi whole-genome sequencing on each WM cell line to verify the regions spanning the immunoglobulin loci and their associated regulatory regions. Results BCR sequencing identified a single dominant IGH and IGK/L rearrangement in each line, consistent with their clonal origin, along with only infrequent secondary rearrangements (< 30 reads). The ratio of light- to heavy-chain (L:H) transcripts ranged from 20—100 across the cell lines and correlated with the level of secreted IgM. Analysis of the PacBio data confirmed that the intronic regulatory sequence between the rearranged VDJ and constant regions is conserved in BCWM.1 and RPCI-WM1 but is disrupted by a gap in MWCL-1. Methylation profiles derived from the PacBio kinetic signals were broadly similar across the IGH region in all three cell lines, indicating that large-scale methylation differences are unlikely to account for variation in IgM expression. Conclusion The availability of monoclonal WM cell lines, coupled with BCR and PacBio sequencing, provides a platform to study the regulation of human IGH. Funding Source n/a Topic Categories Immune Response Regulation: Molecular Mechanisms (IRM)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (5)

K

Kailey Paar

M

Mona Karbalivand

University of New Hampshire

J

Joseph Sevigny

University of New Hampshire

W

W Kelley Thomas

University of New Hampshire

S

Sherine Elsawa

1University of New Hampshire, Molecular, Cellular and Biomedical Sciences, Durham, United States